Sanofi has launched its new insulin treatment Toujeo in the UK, and says it will be priced at the same level as its big seller Lantus. The pricing decision matches Sanofi's approach in the US ...

Lantus – said to be the most administered basal insulin across the world – continues to make blockbuster sales, bringing in almost $775 million for Sanofi in the first quarter of this year.

This March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. (AP Photo/Pablo Salinas) LOS ANGELES (CN) — A Superior Court judge, on Tuesday, told lawyers for the state of ...